MENU
INKT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MiNK Therapeutics (INKT) Ownership - Who owns MiNK Therapeutics?
Profile
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8250
Employees
31
Web
https://www.minktherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.31M
P/E Ratio
N/A
Total Cash
6.33M
Projected Growth
N/A
Total Debt
4.61M
Revenue
N/A
Risk (Beta)
0.05
Dividend Yield
N/A
Total Cash/Share
0.16
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INKT
Capitalization
21.3M
P/E Ratio
N/A
Risk (Beta)
0.05
Dividend Yield
N/A
Total Cash
6.33M
Total Cash/Share
0.16
Total Debt
4.61M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-17.55M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
395
Current Ratio
0.89
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-14.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-185.76
Shares Held By Institutions
975K
Shares Outstanding - Current
39.5M
Total Liabilities
24.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-49.654
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8250
Employees
31
Web
https://www.minktherapeutics.com